Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

HIV Infection

Free Subscription Articles published in Lancet Retrieve available abstracts of 46 articles: HTML format

Single Articles

December 2025
1. MAJAHA M, Chikwari CD, Kizito S, Moyo D, et al
   HIV and alcohol misuse among miners in Zimbabwe.
   Lancet. 2025;404:2538.
   PubMed    
   
   
   April 2025
2. UNEMO M, Wi T
   Gepotidacin shows promise for the treatment of uncomplicated gonorrhoea.
   Lancet. 2025 Apr 11:S0140-6736(25)00680-4. doi: 10.1016/S0140-6736(25)00680.
   PubMed    
   
   
   
3. ROSS JDC, Wilson J, Workowski KA, Taylor SN, et al
   Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study.
   Lancet. 2025 Apr 11:S0140-6736(25)00628-2. doi: 10.1016/S0140-6736(25)00628.
   PubMed     Abstract available
   
   
   
4. NDEMBI N, Karuna S, Cowden J, Cagigi A, et al
   Accelerating vaccine development in Africa: lessons from HIV research.
   Lancet. 2025 Apr 10:S0140-6736(25)00564-1. doi: 10.1016/S0140-6736(25)00564.
   PubMed    
   
   
   
5. SIDIBE M, Makgoba TC, Paul B, Brilliant B, et al
   Accelerating domestic investments to end AIDS in Africa.
   Lancet. 2025 Apr 8:S0140-6736(25)00685-3. doi: 10.1016/S0140-6736(25)00685.
   PubMed    
   
   
   
6. CLUVER L, Makangila G, Hillis S, Ntwali-N'Konzi JP, et al
   Protecting Africa's children from extreme risk: a runway of sustainability for PEPFAR programmes.
   Lancet. 2025 Apr 8:S0140-6736(25)00401-5. doi: 10.1016/S0140-6736(25)00401.
   PubMed     Abstract available
   
   
   
7. OKANO JT, Blower S
   Long-acting HIV preventive treatments for remote rural communities.
   Lancet. 2025;405:1143.
   PubMed    
   
   
   March 2025
8. AL ZAMEL AM, Saeed AA, Elmubarak M
   Sudan's war and the burden of HIV: a call for urgent intervention.
   Lancet. 2025 Mar 27:S0140-6736(25)00547-1. doi: 10.1016/S0140-6736(25)00547.
   PubMed    
   
   
   
9. PRASAD A
   Rachael Burke: integrating equitable HIV and TB research and care.
   Lancet. 2025 Mar 17:S0140-6736(25)00515-X. doi: 10.1016/S0140-6736(25)00515.
   PubMed    
   
   
   
10. PRASAD A
    Aliasgar Esmail: innovation in TB and HIV research and medicine.
    Lancet. 2025 Mar 17:S0140-6736(25)00514-8. doi: 10.1016/S0140-6736(25)00514.
    PubMed    
    
    
    
11. JOGIRAJU V, Pawar P, Yager J, Ling J, et al
    Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study.
    Lancet. 2025 Mar 10:S0140-6736(25)00405-2. doi: 10.1016/S0140-6736(25)00405.
    PubMed     Abstract available
    
    
    
12. RYOM L
    The potential for annual long-acting HIV pre-exposure prophylaxis.
    Lancet. 2025 Mar 10:S0140-6736(25)00452-0. doi: 10.1016/S0140-6736(25)00452.
    PubMed    
    
    
    
13. BARMANIA S
    Research focus: Institute of HIV Research and Innovation.
    Lancet. 2025;405:771.
    PubMed    
    
    
    
14. TRAJMAN A, Campbell JR, Kunor T, Ruslami R, et al
    Tuberculosis.
    Lancet. 2025;405:850-866.
    PubMed     Abstract available
    
    
    February 2025
15. DEVI S
    A new era for HIV in the Philippines?
    Lancet. 2025;405:611-612.
    PubMed    
    
    
    
16. HOLT E
    Ukraine HIV services severely curtailed by US aid freeze.
    Lancet. 2025;405:455.
    PubMed    
    
    
    
17. RATEVOSIAN J, Millett G, Honermann B, Bennett S, et al
    PEPFAR under review: what's at stake for PEPFAR's future.
    Lancet. 2025 Feb 7:S0140-6736(25)00258-2. doi: 10.1016/S0140-6736(25)00258.
    PubMed    
    
    
    January 2025
18. BROSIUS I, Vakaniaki EH, Mukari G, Munganga P, et al
    Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study.
    Lancet. 2025 Jan 29:S0140-6736(25)00047-9. doi: 10.1016/S0140-6736(25)00047.
    PubMed     Abstract available
    
    
    
19. KAMAL-YANNI M, Gangte L, Kittitrakul C, Meyer S, et al
    Is MSF changing course on access to medicines?
    Lancet. 2025;405:124-125.
    PubMed    
    
    
    November 2024
20. THE LANCET
    Triumphs and threats: HIV in 2024.
    Lancet. 2024;404:2131.
    PubMed    
    
    
    
21. BENDER IGNACIO RA, Shapiro AE, Montano MA, Titanji BK, et al
    An urgent call to address the intersection of mpox and HIV in Africa.
    Lancet. 2024 Nov 28:S0140-6736(24)02542-X. doi: 10.1016/S0140-6736(24)02542.
    PubMed    
    
    
    
22. NORHEIM OF, Chang AY, Bolongaita S, Barraza-Llorens M, et al
    Halving premature death and improving quality of life at all ages: cross-country analyses of past trends and future directions.
    Lancet. 2024 Nov 20:S0140-6736(24)02417-6. doi: 10.1016/S0140-6736(24)02417.
    PubMed     Abstract available
    
    
    
23. COUSINS S
    New HIV drugs: access debates.
    Lancet. 2024;404:1797-1798.
    PubMed    
    
    
    September 2024
24. SALEH E, Dousa KM, Babiker A, Rahma NEAA, et al
    Health and humanitarian toll of Sudan's forgotten war.
    Lancet. 2024 Sep 24:S0140-6736(24)01939-1. doi: 10.1016/S0140-6736(24)01939.
    PubMed    
    
    
    August 2024
25. KIZITO S, Nabayinda J, Nabunya P, Ssewamala FM, et al
    HIV and tuberculosis in Uganda: are we neglecting poverty?
    Lancet. 2024;404:844-845.
    PubMed    
    
    
    
26. BASSEY AE
    The health of migrants at the intersection of mpox and HIV.
    Lancet. 2024 Aug 23:S0140-6736(24)01753-7. doi: 10.1016/S0140-6736(24)01753.
    PubMed    
    
    
    
27. MODY A, Sohn AH, Iwuji C, Tan RKJ, et al
    The battle against paediatric HIV is far from over - Authors' reply.
    Lancet. 2024;404:522-523.
    PubMed    
    
    
    
28. VAN DE PERRE P, Tylleskar T
    The battle against paediatric HIV is far from over.
    Lancet. 2024;404:522.
    PubMed    
    
    
    
29. NABAYINDA J, Kizito S, Nagawa A, Ssewamala FM, et al
    Reducing HIV in young women in Uganda: the need for autonomy.
    Lancet. 2024;404:519-520.
    PubMed    
    
    
    
30. SALEEM SM, Haq Z
    Bridging gaps in vertical transmission of HIV, syphilis, and hepatitis B in India.
    Lancet. 2024;404:428-429.
    PubMed    
    
    
    July 2024
31. KIRBY T
    Beatriz Grinsztejn: leading Brazil's response to HIV.
    Lancet. 2024;404:233.
    PubMed    
    
    
    May 2024
32. JAFFAR S
    Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa - Authors' reply.
    Lancet. 2024;403:2292.
    PubMed    
    
    
    
33. CAI S, Xu Z, Zhao Y, Zuhlke L, et al
    Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.
    Lancet. 2024;403:2291.
    PubMed    
    
    
    
34. HAVLIR D, Kamya MR, Petersen M
    Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.
    Lancet. 2024;403:2291-2292.
    PubMed    
    
    
    
35. MAERTENS GN, Purcell DFJ, Rosadas C, Bradshaw D, et al
    Why not eliminate HTLV-1 while eliminating HIV-1?
    Lancet. 2024;403:2288-2289.
    PubMed    
    
    
    
36. 
    The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa.
    Lancet. 2024 May 20:S0140-6736(24)00980-2. doi: 10.1016/S0140-6736(24)00980.
    PubMed    
    
    
    
37. LEWNARD JA, Charani E, Gleason A, Hsu LY, et al
    Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis.
    Lancet. 2024 May 20:S0140-6736(24)00862-6. doi: 10.1016/S0140-6736(24)00862.
    PubMed     Abstract available
    
    
    
38. MENDELSON M, Lewnard JA, Sharland M, Cook A, et al
    Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach.
    Lancet. 2024 May 20:S0140-6736(24)01019-5. doi: 10.1016/S0140-6736(24)01019.
    PubMed     Abstract available
    
    
    April 2024
39. TUTLAM NT, Kizito S, Liyew TW, Ssewamala FM, et al
    HIV among refugee youth in Uganda: unmasking the crisis.
    Lancet. 2024;403:1536-1537.
    PubMed    
    
    
    
40. 
    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed     Abstract available
    
    
    
41. 
    Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    PubMed     Abstract available
    
    
    March 2024
42. BEYRER C, Kamarulzaman A, Isbell M, Amon J, et al
    Under threat: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2024 Mar 20:S0140-6736(24)00302-7. doi: 10.1016/S0140-6736(24)00302.
    PubMed    
    
    
    
43. WATTS G
    Andrew Kerkhoff: award-winning TB and HIV physician-scientist.
    Lancet. 2024 Mar 15:S0140-6736(24)00539-7. doi: 10.1016/S0140-6736(24)00539.
    PubMed    
    
    
    
44. KANKASA C, Mennecier A, Sakana BLD, Moles JP, et al
    Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
    Lancet. 2024 Mar 11:S0140-6736(23)02464-9. doi: 10.1016/S0140-6736(23)02464.
    PubMed     Abstract available
    
    
    
45. MUTALE W, Herce ME
    Closing the gap in paediatric HIV infections: how available tools and technology can accelerate progress towards ending AIDS by 2030.
    Lancet. 2024 Mar 11:S0140-6736(24)00366-0. doi: 10.1016/S0140-6736(24)00366.
    PubMed    
    
    
    
46. 
    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.